I wonder how much this fast-talking medical bureaucrat actually matters in comparison, say, with an FDA middling manager who did not include in his guidance to Cytodyn a request for "certain information needed to complete a substantive review" of our combo BLA? Anything or nothing at all?
(0)
(0)
CytoDyn Inc (CYDY) Stock Research Links
Whatever happens, we have got
Le-Ron-Li-Mab, and they have not.